iRhythm Holdings to Report First Quarter 2026 Financial Results on April 30, 2026
iRhythm Holdings (NASDAQ:IRTC) will report first quarter 2026 financial results after market close on Thursday, April 30, 2026.
Rhea-AI Summary
iRhythm Holdings (NASDAQ:IRTC) will report first quarter 2026 financial results after market close on Thursday, April 30, 2026. Management will host a conference call at 1:30 p.m. PT / 4:30 p.m. ET with a live and archived webcast available.
Investors may access the webcast via the Quarterly Results section of the company investor website at investors.irhythmtech.com.
Details
News Market Reaction – IRTC
On Apr 17, the first trading day after this news, IRTC closed 2.21% above the previous close.
Data tracked by StockTitan Argus for the Apr 17 session.
Key Figures
- Earnings period
- First quarter 2026
- Period for upcoming financial results
- Earnings date
- April 30, 2026
- Scheduled Q1 2026 results release after market close
- Conference call time
- 1:30 p.m. PT / 4:30 p.m. ET
- Start time for Q1 2026 results call and webcast
Previous Earnings date Reports
-
Announced Q4 and full-year 2025 earnings release timing and conference call details.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN FRANCISCO, April 16, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the first quarter 2026 after the close of trading on Thursday, April 30, 2026. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET.
Interested parties may access a live and archived webcast of the conference call on the “Quarterly Results” section of the company’s investor website at investors.irhythmtech.com.
About iRhythm Holdings, Inc.
iRhythm is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information. Through a relentless focus on patient care, iRhythm’s vision is to deliver better data, better insights, and better health for all.
Investor Contact
investors@irhythmtech.com
Media Contact
Kassandra Perry
mediarelations@irhythmtech.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.